abstract |
This invention relates to a combination of tetomilast and at least one beta 2 -adrenergic receptor agonist for use in the treatment of a disease, disorder, or condition. The invention further relates to the combination of an anti-inflammatory steroid, tetomilast and at least one beta 2 -adrenergic receptor agonist for use in the treatment of a disease, disorder, or condition. |